Neurosurgery Navigation & Therapy - Disposable Products was ClearPoint Neuro’s largest product and service line in fiscal 2025, bringing in $14.83M of $51.80M (29%).
| Product and Service | FY 2017 | FY 2018 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|
| Neurosurgery Navigation & Therapy - Disposable Products | — | $7.59M | $10.29M | $14.83M | ||||
| Neurosurgery Navigation & Therapy | — | — | $10.29M | $14.83M | ||||
| Biologics & Drug Delivery - Services And License Fees | $5.43M | $11.45M | $11.70M | $11.70M | ||||
| Functional Neurosurgery Navigation & Therapy - Disposable Products | $7.59M | — | — | — | ||||
| Product Revenue | — | — | — | — | ||||
| Subtotal - Functional Neurosurgery Navigation & Therapy | — | — | — | — | ||||
| Product - Functional Neurosurgery | — | — | — | — | ||||
| Functional Neurology | — | — | — | — | ||||
| Biologics & Drug Delivery - Disposable Products | $3.69M | $2.15M | $5.61M | $7.34M | ||||
| Biologics & Drug Delivery - Services | — | — | — | — | ||||
| Functional Neurosurgery Navigation & Therapy - Services | $1.54M | — | — | — | ||||
| Capital Equipment & Software - Systems And Software Products | $1.51M | $860.00K | $2.74M | $1.69M | ||||
| Capital Equipment | — | — | — | — | ||||
| Neurosurgery Navigation & Therapy - Services | — | $931.00K | — | — | ||||
| Product - Biologics & Drug Delivery | — | — | — | — | ||||
| Capital Equipment & Software - Services | $795.00K | $973.00K | $1.06M | $1.41M | ||||
| Biologics & Drug Delivery | — | — | — | — | ||||
| Product - Capital Equipment | — | — | — | — | ||||
| Services - Capital Equipment & Other | — | — | — | — | ||||
| Capital Equipment & Other | — | — | — | — | ||||
| Service & Other Revenues | — | — | — | — | ||||
| Capitalequipmentandother1Member | — | — | — | — | ||||
| Services - Biologics & Drug Delivery | — | — | — | — | ||||
| Service - Therapy | — | — | — | — | ||||
| Total | $20.55M | $23.96M | $41.68M | $51.80M |
ClearPoint Neuro brought in $51.80M from its six product and service lines in fiscal 2025, the year ended December 31, 2025. That was up 24.3% from $41.68M in fiscal 2024. Neurosurgery Navigation & Therapy - Disposable Products was the largest at $14.83M (28.6%), ahead of Neurosurgery Navigation & Therapy at $14.83M (28.6%) and Biologics & Drug Delivery - Services And License Fees at $11.70M (22.6%). The other three lines brought in $10.44M combined.
Compared with fiscal 2024, Neurosurgery Navigation & Therapy - Disposable Products grew fastest, up 44.2% to $14.83M, while Capital Equipment & Software - Systems And Software Products fell the most, down 38.2% to $1.69M.
ClearPoint Neuro began breaking out Neurosurgery Navigation & Therapy - Disposable Products in fiscal 2023 and Neurosurgery Navigation & Therapy in fiscal 2024. ClearPoint Neuro stopped reporting Functional Neurosurgery Navigation & Therapy - Disposable Products ($7.59M in fiscal 2022), Functional Neurosurgery Navigation & Therapy - Services ($1.54M in fiscal 2022) and Neurosurgery Navigation & Therapy - Services ($931.00K in fiscal 2023) as separate lines.
ClearPoint Neuro (CLPT) reports its revenue by product and service. In fiscal 2025, Neurosurgery Navigation & Therapy - Disposable Products was its largest product and service line, bringing in $14.83M (28.6% of the total), followed by Neurosurgery Navigation & Therapy at $14.83M (28.6%).
Neurosurgery Navigation & Therapy - Disposable Products was ClearPoint Neuro's largest product and service line in fiscal 2025, bringing in $14.83M, or 28.6% of the $51.80M total across its six product and service lines.
Among ClearPoint Neuro's product and service lines that make up at least 2% of revenue, Neurosurgery Navigation & Therapy - Disposable Products grew fastest in fiscal 2025, up 44.2% from $10.29M to $14.83M.
Every figure comes from ClearPoint Neuro's annual financial filings, as reported. Each line keeps the name ClearPoint Neuro gives it, and years follow its fiscal calendar.
ClearPoint Neuro's revenue by product and service goes back to fiscal 2017, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.